Indium In 111 Oxyquinoline Solution
Product Images NDC 17156-021

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Indium In 111 Oxyquinoline (NDC 17156-021). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medi-physics Inc. Dba Ge Healthcare., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Principal Display Panel (1 mL Vial Label)
Indium In 111 Oxyquinoline Solution is a radiolabeling agent used for autologous leukocytes. It contains <0.1mcg Indium, 50mcg 8-hydroxyquinoline, ~100mcg polysorbate 80, 6mg (N-2-hydroxyethylpiperazine-N-2 ethane sulfonic acid), HEPES buffer and 0.75% Sodium Chloride Injection. It is pH adjusted with sodium hydroxide and hydrochloric acid. It is manufactured by GE Healthcare, Medi-Physics in the USA. It is a radioactive material and must be used with caution. Lot number and expiration date details are also provided. Refer to prescribing information for more details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.